BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28587064)

  • 21. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E
    Ohkura N; Yoshiba K; Yoshiba N; Oda Y; Edanami N; Ohshima H; Takenaka S; Okiji T; Noiri Y
    J Endod; 2023 Apr; 49(4):410-418. PubMed ID: 36758673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3β-mediated signal transduction in colon cancer cells.
    Yu S; Hou Q; Sun H; Liu J; Li J
    Mol Med Rep; 2015 Nov; 12(5):7169-75. PubMed ID: 26352871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E
    Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
    FASEB J; 2018 May; 32(5):2827-2840. PubMed ID: 29401596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
    Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EP4 receptor as a novel promising therapeutic target in colon cancer.
    Karpisheh V; Joshi N; Zekiy AO; Beyzai B; Hojjat-Farsangi M; Namdar A; Edalati M; Jadidi-Niaragh F
    Pathol Res Pract; 2020 Dec; 216(12):153247. PubMed ID: 33190014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E
    Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
    Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17beta-estradiol inhibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells.
    Lai TY; Chen LM; Lin JY; Tzang BS; Lin JA; Tsai CH; Lin YM; Huang CY; Liu CJ; Hsu HH
    Mol Cell Biochem; 2010 Sep; 342(1-2):63-70. PubMed ID: 20446020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro.
    Wang Y; Lai S; Tang J; Feng C; Liu F; Su C; Zou W; Chen H; Xu D
    Mol Med Rep; 2017 Jul; 16(1):639-646. PubMed ID: 28560401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EP2/4 Receptors Promote the Synthesis of PGE
    Zhang C; Wang L; Li T; Mao W; Liu B; Cao J
    J Pharmacol Exp Ther; 2020 Feb; 372(2):175-184. PubMed ID: 31732699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils.
    Lavoie JC; Simard M; Kalkan H; Rakotoarivelo V; Huot S; Di Marzo V; Côté A; Pouliot M; Flamand N
    J Leukoc Biol; 2024 May; 115(6):1183-1189. PubMed ID: 38345417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prostaglandin E2 receptor EP4 is integral to a positive feedback loop for prostaglandin E2 production in human macrophages infected with Mycobacterium tuberculosis.
    Nishimura T; Zhao X; Gan H; Koyasu S; Remold HG
    FASEB J; 2013 Sep; 27(9):3827-36. PubMed ID: 23759445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
    Okuyama T; Ishihara S; Sato H; Rumi MA; Kawashima K; Miyaoka Y; Suetsugu H; Kazumori H; Cava CF; Kadowaki Y; Fukuda R; Kinoshita Y
    J Lab Clin Med; 2002 Aug; 140(2):92-102. PubMed ID: 12228765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.